Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
grade F 0.9051 -0.53% 0.00
MYO closed down 0.53 percent on Friday, May 24, 2019, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MYO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -0.53%
Lower Bollinger Band Walk Weakness -0.53%

Older signals for MYO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Medical Specialties Organ Systems Multiple Sclerosis Neurological Disorders Amyotrophic Lateral Sclerosis Stroke Podiatry Skeletal System Muscular System Neurotrauma Orthopedics
Is MYO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.29
52 Week Low 0.8201
Average Volume 101,598
200-Day Moving Average 1.6079
50-Day Moving Average 1.1726
20-Day Moving Average 1.1168
10-Day Moving Average 1.0049
Average True Range 0.0795
ADX 36.98
+DI 7.0581
-DI 29.4821
Chandelier Exit (Long, 3 ATRs ) 1.0615
Chandelier Exit (Short, 3 ATRs ) 1.0586000000000001
Upper Bollinger Band 1.3796
Lower Bollinger Band 0.854
Percent B (%b) 0.1
BandWidth 47.063037
MACD Line -0.0789
MACD Signal Line -0.0527
MACD Histogram -0.0262
Fundamentals Value
Market Cap 5.51 Million
Num Shares 6.09 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.11
Price-to-Sales 14.12
Price-to-Book 4.12
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.03 0.97 1.02
Resistance 2 (R2) 0.97 0.93 0.97 1.01
Resistance 1 (R1) 0.94 0.91 0.95 0.95 1.00
Pivot Point 0.88 0.88 0.89 0.89 0.88
Support 1 (S1) 0.85 0.84 0.86 0.86 0.81
Support 2 (S2) 0.79 0.82 0.80 0.80
Support 3 (S3) 0.76 0.79 0.79
Support 4 (S4) 0.77